{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:23:33Z","timestamp":1767925413560,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Diabetes UK (GB)","award":["12\/0004457"],"award-info":[{"award-number":["12\/0004457"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00210-016-1243-5","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:29:35Z","timestamp":1460633375000},"page":"769-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance"],"prefix":"10.1007","volume":"389","author":[{"given":"Bosede O.","family":"Owolabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Opeolu O.","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh K.","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser H. A.","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"1243_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.regpep.2013.10.006","volume":"187","author":"S Attoub","year":"2013","unstructured":"Attoub S, Arafat H, Mechkarska M, Conlon JM (2013) Anti-tumour activities of the host-defense peptide hymenochirin-1B. Regul Pept 187:51\u201356","journal-title":"Regul Pept"},{"key":"1243_CR2","first-page":"1","volume":"4","author":"ME Cerf","year":"2013","unstructured":"Cerf ME (2013) Beta cell dysfunction and insulin resistance. Front Endocrinol 4:1\u201312","journal-title":"Front Endocrinol"},{"key":"1243_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.peptides.2014.04.019","volume":"57","author":"JM Conlon","year":"2014","unstructured":"Conlon JM, Mechkarska M, Lukic ML, Flatt PR (2014) Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides 57:67\u201377","journal-title":"Peptides"},{"key":"1243_CR4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/en.2011-1499","volume":"153","author":"PE Cryer","year":"2012","unstructured":"Cryer PE (2012) Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 153:1039\u20131048","journal-title":"Endocrinology"},{"key":"1243_CR5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1517\/14656566.2012.730519","volume":"13","author":"G Derosa","year":"2012","unstructured":"Derosa G, Carbone A, D\u2019Angelo A, Querci F, Fogari E, Cicero AF, Maffioli P (2012) A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and \u03b2-cell function. Expert Opin Pharmacother 13:2433\u20132442","journal-title":"Expert Opin Pharmacother"},{"key":"1243_CR6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","volume":"20","author":"PR Flatt","year":"1981","unstructured":"Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice. Diabetologia 20:573\u2013577","journal-title":"Diabetologia"},{"key":"1243_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbadis.2008.10.019","volume":"1792","author":"S Fr\u00f6jd\u00f6","year":"2009","unstructured":"Fr\u00f6jd\u00f6 S, Vidal H, Pirola L (2009) Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans. Biochim Biophys Acta 1792:83\u201392","journal-title":"Biochim Biophys Acta"},{"key":"1243_CR8","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc10-0482","volume":"33","author":"R Garg","year":"2010","unstructured":"Garg R, Chen W, Pendergrass M (2010) Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin. A retrospective observational pharmacy claims analysis. Diabetes Care 33:2349\u20132354","journal-title":"Diabetes Care"},{"key":"1243_CR9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study 2013","year":"2015","unstructured":"Global Burden of Disease Study 2013 (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the global burden of disease study 2013. Lancet 386:743\u2013800","journal-title":"Lancet"},{"key":"1243_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00007890-198510000-00018","volume":"40","author":"M Goto","year":"1985","unstructured":"Goto M, Maki T, Kiyoizumi T, Satomi S, Monaco AP (1985) An improved method for isolation of mouse pancreatic islets. Transplantation 40:437\u2013438","journal-title":"Transplantation"},{"key":"1243_CR11","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.2337\/dc11-s227","volume":"34","author":"JJ Holst","year":"2011","unstructured":"Holst JJ, Knop FK, Vilsboll T, Krarup T, Madsbad S (2011) Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care 34:S251\u2013S257","journal-title":"Diabetes Care"},{"key":"1243_CR12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","volume":"52","author":"RL Hull","year":"2003","unstructured":"Hull RL, Andrikopoulos S, Verchere CB, Vidal J, Wang F, Cnop M, Prigeon RL, Kahn SE (2003) Increased dietary fat promotes islet amyloid formation and \u03b2-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52:372\u2013379","journal-title":"Diabetes"},{"key":"1243_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physiolgenomics.00050.2008","volume":"36","author":"Y Imai","year":"2008","unstructured":"Imai Y, Patel HR, Doliba NM, Matschinsky FM, Tobias JW, Ahima RS (2008) Analysis of gene expression in pancreatic islets from diet-induced obese mice. Physiol Genomics 36:43\u201351","journal-title":"Physiol Genomics"},{"key":"1243_CR14","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.4158\/EP11264.CR","volume":"18","author":"S Iyer","year":"2011","unstructured":"Iyer S, Drake JA 3rd, West R, Mendez C, Tanenberg R (2011) Case report of acute necrotizing pancreatitis associated with combination treatment of sitagliptin and exenatide. Endocr Pract 18:e10\u2013e13","journal-title":"Endocr Pract"},{"key":"1243_CR15","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/clinchem\/43.11.2183","volume":"43","author":"R Johnson","year":"1997","unstructured":"Johnson R, McNutt P, MacMahon S, Robson R (1997) Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem 43:2183\u20132184","journal-title":"Clin Chem"},{"key":"1243_CR16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840\u2013846","journal-title":"Nature"},{"key":"1243_CR17","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0168-8227(11)70011-0","volume":"93","author":"K Kazakos","year":"2011","unstructured":"Kazakos K (2011) Incretin effect: GLP-1, GIP, DPP4. Diabetes Res Clin Pract 93:S32\u2013S36","journal-title":"Diabetes Res Clin Pract"},{"key":"1243_CR18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/diacare.25.3.620","volume":"25","author":"JA Marshall","year":"2002","unstructured":"Marshall JA, Bessesen DH (2002) Dietary fat and the development of type 2 diabetes. Diabetes Care 25:620\u2013622","journal-title":"Diabetes Care"},{"key":"1243_CR19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2012.04.015","volume":"84","author":"CMA Martin","year":"2012","unstructured":"Martin CMA, Gault VA, McClean S, Flatt PR, Irwin N (2012) Degradation, insulin secretion, glucose-lowering and GIP additive actions of palmitate-derivatised analogues of xenin-25. Biochem Pharmacol 84:312\u2013319","journal-title":"Biochem Pharmacol"},{"key":"1243_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.peptides.2012.03.029","volume":"35","author":"M Mechkarska","year":"2012","unstructured":"Mechkarska M, Prajeep M, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM (2012) The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae). Peptides 35:269\u2013275","journal-title":"Peptides"},{"key":"1243_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.peptides.2013.10.015","volume":"50","author":"M Mechkarska","year":"2013","unstructured":"Mechkarska M, Prajeep M, Radosavljevic GD, Jovanovic IP, Al Baloushi A, Sonnevend A, Lukic ML, Conlon JM (2013) An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties. Peptides 50:153\u2013159","journal-title":"Peptides"},{"key":"1243_CR22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db13-1013","volume":"63","author":"T Mezza","year":"2014","unstructured":"Mezza T, Muscogiuri G, Sorice GP, Clemente G, Hu J, Pontecorvi A, Holst JJ, Giaccari A, Kulkarni RN (2014) Insulin resistance alters islet morphology in non-diabetic humans. Diabetes 63:995\u20131007","journal-title":"Diabetes"},{"key":"1243_CR23","doi-asserted-by":"crossref","first-page":"e78560","DOI":"10.1371\/journal.pone.0078560","volume":"8","author":"RC Moffett","year":"2013","unstructured":"Moffett RC, Irwin N, Francis JM, Flatt PR (2013) Alterations of glucose-dependent insulinotropic polypeptide and expression of genes involved in mammary gland and adipose tissue lipid metabolism during pregnancy and lactation. PLoS One 8:e78560","journal-title":"PLoS One"},{"key":"1243_CR24","doi-asserted-by":"crossref","first-page":"e96863","DOI":"10.1371\/journal.pone.0096863","volume":"9","author":"RC Moffett","year":"2014","unstructured":"Moffett RC, Vasu S, Thorens B, Drucker DJ, Flatt PR (2014) Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy. PLoS One 9:e96863","journal-title":"PLoS One"},{"key":"1243_CR25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/dmrr.2608","volume":"31","author":"RC Moffett","year":"2015","unstructured":"Moffett RC, Patterson S, Irwin N, Flatt PR (2015) Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL\/KsJ db\/db mice with degenerative diabetes. Diabetes Metab Res Rev 31:248\u2013255","journal-title":"Diabetes Metab Res Rev"},{"key":"1243_CR26","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.2337\/dcS13-2004","volume":"36","author":"MA Nauck","year":"2013","unstructured":"Nauck MA, Friedrich N (2013) Do GLP-1\u2013based therapies increase cancer risk? Diabetes Care 36:S245\u2013S252","journal-title":"Diabetes Care"},{"key":"1243_CR27","doi-asserted-by":"crossref","unstructured":"Obanda DN, Ribnicky D, Yu Y, Stephens J, Cefalu WT (2016) An extract of Urtica dioica L. mitigates obesity induced insulin resistance in mice skeletal muscle via protein phosphatase 2\u00a0A (PP2A). Sci Rep 6:22222","DOI":"10.1038\/srep22222"},{"key":"1243_CR28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2012.12.116","volume":"431","author":"OO Ojo","year":"2013","unstructured":"Ojo OO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2013) Frog skin peptides (tigerinin-1R, magainin-AM1, \u2212AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cells. Biochem Biophys Res Commun 431:14\u201318","journal-title":"Biochem Biophys Res Commun"},{"key":"1243_CR29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbagen.2014.10.011","volume":"1850","author":"OO Ojo","year":"2015","unstructured":"Ojo OO, Srinivasan DK, Owolabi BO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2015a) Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice. Biochim Biophys Acta 1850:80\u201387","journal-title":"Biochim Biophys Acta"},{"key":"1243_CR30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biochi.2014.11.018","volume":"109","author":"OO Ojo","year":"2015","unstructured":"Ojo OO, Srinivasan DK, Owolabi BO, Flatt PR, Abdel-Wahab YHA (2015b) Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes. Biochimie 109:18\u201326","journal-title":"Biochimie"},{"key":"1243_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/obr.12229","volume":"16","author":"S O\u2019Neill","year":"2015","unstructured":"O\u2019Neill S, O\u2019Driscoll L (2015) Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 16:1\u201312","journal-title":"Obes Rev"},{"key":"1243_CR32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1586\/17512433.2016.1121808","volume":"9","author":"L \u00d8stergaard","year":"2016","unstructured":"\u00d8stergaard L, Frandsen CS, Madsbad S (2016) Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review. Expert Rev Clin Pharmacol 9:241\u2013265","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1243_CR33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00726-015-2107-x","volume":"48","author":"BO Owolabi","year":"2016","unstructured":"Owolabi BO, Ojo OO, Srinivasan DK, Conlon JM, Flatt PR, Abdel-Wahab YHA (2016) In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study. Amino Acids 48:535\u2013547","journal-title":"Amino Acids"},{"key":"1243_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mce.2014.12.001","volume":"401","author":"AC Poletto","year":"2015","unstructured":"Poletto AC, Furuya DT, David-Silva A, Ebersbach-Silva P, Santos CL, Correa-Giannella ML, Passarelli M, Machado UF (2015) Oleic and linoleic fatty acids downregulate Slc2a4\/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells. Mol Cell Endocrinol 401:65\u201372","journal-title":"Mol Cell Endocrinol"},{"key":"1243_CR35","doi-asserted-by":"crossref","first-page":"e86815","DOI":"10.1371\/journal.pone.0086815","volume":"9","author":"R Roat","year":"2014","unstructured":"Roat R, Rao V, Doliba NM, Matschinsky FM, Tobias JW, Garcia E, Ahima RS, Imai Y (2014) Alterations of pancreatic islet structure, metabolism and gene expression in diet-induced obese C57BL\/6\u00a0J mice. PLoS One 9:e86815","journal-title":"PLoS One"},{"key":"1243_CR36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.taap.2014.01.021","volume":"276","author":"R Rouse","year":"2014","unstructured":"Rouse R, Xu L, Stewart S, Zhang J (2014) High fat diet and GLP-1 drugs induce pancreatic injury in mice. Toxicol Appl Pharmacol 276:104\u2013114","journal-title":"Toxicol Appl Pharmacol"},{"key":"1243_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2015.06.042","volume":"764","author":"DK Srinivasan","year":"2015","unstructured":"Srinivasan DK, Ojo OO, Owolabi BO, Conlon JM, Flatt PR, Abdel-Wahab YHA (2015) The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice. Eur J Pharmacol 764:38\u201347","journal-title":"Eur J Pharmacol"},{"key":"1243_CR38","doi-asserted-by":"publisher","unstructured":"Turner N, Zeng XY, Osborne B, Rogers S, Ye JM (2016) Repurposing drugs to target the diabetes epidemic. Trends Pharmacol Sci. doi: 10.1016\/j.tips.2016.01.007","DOI":"10.1016\/j.tips.2016.01.007"},{"key":"1243_CR39","doi-asserted-by":"crossref","first-page":"F77","DOI":"10.1530\/ERC-12-0111","volume":"19","author":"R Vangoitsenhoven","year":"2012","unstructured":"Vangoitsenhoven R, Mathieu C, Van der Schueren B (2012) GLP1 and cancer: friend or foe? Endocr Relat Cancer 19:F77\u2013F88","journal-title":"Endocr Relat Cancer"},{"key":"1243_CR40","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930\u20131935","journal-title":"J Clin Endocrinol Metab"},{"key":"1243_CR41","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.2337\/diabetes.53.suppl_3.S215","volume":"53","author":"MS Winzell","year":"2004","unstructured":"Winzell MS, Ahren B (2004) The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53:S215\u2013S219","journal-title":"Diabetes"},{"key":"1243_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11684-013-0262-6","volume":"7","author":"J Ye","year":"2013","unstructured":"Ye J (2013) Mechanisms of insulin resistance in obesity. Front Med 7:14\u201324","journal-title":"Front Med"},{"key":"1243_CR43","first-page":"181","volume":"26","author":"SM Younan","year":"2007","unstructured":"Younan SM, Rashed LA (2007) Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors. Gen Physiol Biophys 26:181\u2013193","journal-title":"Gen Physiol Biophys"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-016-1243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-016-1243-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-016-1243-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:30:35Z","timestamp":1600450235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-016-1243-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1007\/s00210-016-1243-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]}}}